Free Trial

BioRestorative Therapies (BRTX) Earnings Date, Estimates & Call Transcripts

BioRestorative Therapies logo
$1.56
+0.03 (+1.96%)
(As of 11/1/2024 08:56 PM ET)

BioRestorative Therapies Latest Earnings Summary

Latest Q2 2024
Earnings Date
Aug. 13Estimated
Actual EPS
(Aug. 13)
-$0.50 Beat By $0.06
Consensus EPS
(Aug. 13)
-$0.56

BioRestorative Therapies posted Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.50, which topped analysts' consensus estimates of -$0.56 by $0.06. Quarterly revenue was reported to be $0.09 million, above analyst estimates of $0.03 million. With a trailing EPS of -$2.04, BioRestorative Therapies' earnings are expected to grow next year, from ($3.52) to ($2.53) per share.

Get BioRestorative Therapies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioRestorative Therapies and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioRestorative Therapies Analyst EPS Estimates

Current Year EPS Consensus Estimate:($3.52) EPS
Next Year EPS Consensus Estimate: ($2.53) EPS

BioRestorative Therapies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/13/2024Q2 2024-$0.56-$0.50+$0.06-$0.50$0.03M$0.09M
6/11/2024Q1 2024-$0.51-$0.53 -$0.02-$0.73$0.03M$0.04M
3/29/2024Q4 2023--$0.57 -$0.57-$0.57$0.03M$0.02M
11/13/2023Q3 2023-$0.68-$0.64+$0.04-$0.64$0.03M$0.03M
8/11/2023Q2 2023-$1.56-$0.77+$0.79-$0.77$0.03M$0.07M
5/12/2023Q1 2023-$1.26-$1.53 -$0.27-$1.53$0.03M$0.03M
3/24/2023Q4 2022--$1.18 -$1.18-$1.18--
11/14/2022Q3 2022-$0.49-$1.28 -$0.79-$1.28-$0.03M

BioRestorative Therapies Earnings - Frequently Asked Questions

BioRestorative Therapies (OTCMKTS:BRTX) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on BRTX's earnings history.

In the previous quarter, BioRestorative Therapies (OTCMKTS:BRTX) reported ($0.50) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.06. Learn more on analysts' earnings estimate vs. BRTX's actual earnings.

BioRestorative Therapies (OTCMKTS:BRTX) has a recorded annual revenue of $174,100.00.

BioRestorative Therapies (OTCMKTS:BRTX) has a recorded net income of -$18.50 million. BRTX has generated -$2.04 earnings per share over the last four quarters.

BioRestorative Therapies's earnings are expected to grow from ($3.52) per share to ($2.53) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (OTCMKTS:BRTX) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners